Stock DNA
Pharmaceuticals & Biotechnology
CNY 7,855 Million (Mid Cap)
47.00
NA
0.00%
-0.54
3.45%
2.08
Revenue and Profits:
Net Sales:
283 Million
(Quarterly Results - Jun 2026)
Net Profit:
35 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-10.32%
0%
-10.32%
6 Months
-7.1%
0%
-7.1%
1 Year
-29.71%
0%
-29.71%
2 Years
62.14%
0%
62.14%
3 Years
29.78%
0%
29.78%
4 Years
-20.59%
0%
-20.59%
5 Years
0%
0%
0.0%
Sichuan Huiyu Pharmaceutical Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-13.81%
EBIT Growth (5y)
-48.85%
EBIT to Interest (avg)
84.17
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.59
Sales to Capital Employed (avg)
0.23
Tax Ratio
100.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
12.11%
ROE (avg)
5.57%
Valuation key factors
Factor
Value
P/E Ratio
47
Industry P/E
Price to Book Value
1.63
EV to EBIT
150.52
EV to EBITDA
42.91
EV to Capital Employed
2.38
EV to Sales
4.01
PEG Ratio
1.92
Dividend Yield
NA
ROCE (Latest)
1.58%
ROE (Latest)
3.45%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ
Jun'26
Mar'26
Change(%)
Net Sales
282.60
269.20
4.98%
Operating Profit (PBDIT) excl Other Income
43.00
54.90
-21.68%
Interest
2.80
3.30
-15.15%
Exceptional Items
-2.70
-27.70
90.25%
Consolidate Net Profit
35.30
21.70
62.67%
Operating Profit Margin (Excl OI)
60.60%
107.80%
-4.72%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2026 is 4.98% vs 4.99% in Mar 2026
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2026 is 62.67% vs -11.43% in Mar 2026
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
996.10
1,092.20
-8.80%
Operating Profit (PBDIT) excl Other Income
110.20
143.10
-22.99%
Interest
10.60
13.50
-21.48%
Exceptional Items
-164.50
228.60
-171.96%
Consolidate Net Profit
-30.50
315.90
-109.65%
Operating Profit Margin (Excl OI)
17.90%
57.10%
-3.92%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -8.80% vs 18.23% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -109.65% vs 126.78% in Dec 2024
About Sichuan Huiyu Pharmaceutical Co., Ltd. 
Sichuan Huiyu Pharmaceutical Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






